Optimising the therapeutic efficacy of protein-based drugs against lymph-resident diseases

  • Kaminskas, Lisa (Primary Chief Investigator (PCI))
  • Bulitta, Jurgen (Chief Investigator (CI))
  • Porter, Christopher (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/13 → 31/12/16

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): AUD336,056.00
View all
View less